C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels

Authors: Yi Shi1, Hong-lei Ma1, You-wen Zhuang1,2, Xiao-xi Wang1, Yi Jiang1,2, H. Eric Xu1,2,3
1 The CAS Key Laboratory of Receptor Research, VARI-SIMM Center, Center for Structure and Function of Drug Targets, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2 University of Chinese Academy of Sciences, Beijing 100049, China
3 Laboratory of Structural Sciences, Van Andel Research Institute, Grand Rapids, MI 49503, USA
Correspondence to: Yi Shi:, Yi Jiang:, H. Eric Xu:,
DOI: 10.1038/s41401-019-0247-3
Received: 19 March 2019
Accepted: 5 May 2019
Advance online: 11 June 2019


The polycomb repressive complex 2 (PRC2) catalyzes the methylation of histone H3 on lysine 27 (H3K27) to generate trimethyl-H3K27 (H3K27me3) marks, thereby leading to a repressive chromatin state that inhibits gene expression. C10ORF12 was recently identified as a novel PRC2 interactor. Here, we show that C10ORF12 specifically interacts with PRC2 through its middle region (positions 619–718). C10ORF12 significantly enhances the histone methyltransferase activity of PRC2 in vitro and dramatically increases the total H3K27me3 levels in HeLa cells. C10ORF12 also antagonizes Jarid2, which is an auxiliary factor of the
PRC2.2 subcomplex, to promote increased H3K27me3 levels in HeLa cells. Moreover, C10ORF12 alters the substrate preference of PRC2. These results indicate that C10ORF12 functions as a positive regulator of PRC2 and facilitates PRC2-mediated H3K27me3 modification of chromatin. These findings provide new insight into the roles of C10ORF12 in regulating the activity of the PRC2 complex.
Keywords: PRC2; C10ORF12; H3K27me3; histone methyltransferase; epigenetic regulation; histone modification

Article Options

Download Citation

Cited times in Scopus